Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
3 minute read

Aura Biosciences Announces Interim Phase 2 Data Evaluating Suprachoroidal Administration Of Belzupacap Sarotalocan For The First-Line Treatment Of Patients With Early-Stage Choroidal Melanoma Presented At AAO 2022

By Benzinga Newsdesk
Today, 10:28 AM
Aura Biosciences Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that interim Phase 2

AURA

Read More
3 minute read

Cytokinetics Presents New Data From REDWOOD-HCM OLE in Late Breaking Clinical Trial Session at the HFSA Annual Scientific Meeting

By Charles Gross
Today, 10:28 AM
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data on symptom improvement and quality of life related to treatment with aficamten in REDWOOD-HCM OLE (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM Open Label Extension) in a Late Breaking Clinical Trials session at the Heart Fa

CYTK

Read More
2 minute read

Bond Yields Are Rising Dramatically: These 2 Dividend ETFs Have Them Beat

By Robert Kuczmarski
Today, 10:28 AM
The two-year U.S. treasury yield reached 4.167% on Friday. The 10-year U.S. treasury yield hit 3.762%. This allows the yield curve to remain in an inverse relationship, which typically points to a recession.

CAH

Read More
1 minute read

Aileron Therapeutics Announces Oral Presentation Of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles And Their Stem Cells From Chemotherapy-Induced Damage At The European Society For Dermatological Research Annual Meeting 2022

By Benzinga Newsdesk
Today, 10:28 AM
New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their stem cells   Encore presentation of data presented at Society for Investigative Dermatology in May

ALRN